Close
Back to DNLI Stock Lookup

(DNLI) – Business Wire

Jan 5, 2024 10:00 AM Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Nov 28, 2023 08:00 AM Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
Sep 25, 2023 07:00 AM ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
Apr 7, 2021 07:00 AM Tessera Therapeutics Strengthens Leadership Team to Advance ‘Gene Writing’ Platform & Accelerate Therapeutic Development
Jan 12, 2021 08:00 AM Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine
Mar 25, 2020 09:00 AM Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
Mar 12, 2020 09:00 AM Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
Oct 2, 2019 07:00 AM Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer
Sep 23, 2019 07:00 AM Flagship Pioneering Unveils Omega Therapeutics and Appoints Seasoned BioPharma Executive Mahesh Karande as President and Chief Executive Officer

Back to DNLI Stock Lookup